Fear & Greed Index Moves To 'Extreme Greed' Zone After US Stocks Settle Higher
Portfolio Pulse from Lisa Levin
The CNN Money Fear and Greed index moved to the 'Extreme Greed' zone as US stocks closed slightly higher on Tuesday. Coinbase shares dropped 12% after SEC sued the company, while Hoth Therapeutics shares jumped 78% after announcing positive preclinical results for Alzheimer's treatment. Investors await earnings results from United Natural Foods, Campbell Soup Company, and GameStop.
June 07, 2023 | 7:47 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Coinbase shares dropped 12% after the SEC sued the company in NY federal court.
The SEC lawsuit against Coinbase is a significant negative event for the company, as it may lead to regulatory actions and potential fines. This news is likely to cause a short-term negative impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEUTRAL IMPACT
Investors are awaiting earnings results from Campbell Soup Company.
Earnings results can have a short-term impact on the stock price, depending on whether they meet or exceed market expectations. However, without specific information about the results, it is difficult to predict the direction of the impact.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Investors are awaiting earnings results from GameStop Corp.
Earnings results can have a short-term impact on the stock price, depending on whether they meet or exceed market expectations. However, without specific information about the results, it is difficult to predict the direction of the impact.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Investors are awaiting earnings results from United Natural Foods.
Earnings results can have a short-term impact on the stock price, depending on whether they meet or exceed market expectations. However, without specific information about the results, it is difficult to predict the direction of the impact.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Hoth Therapeutics shares jumped 78% after announcing positive preclinical results for HT-ALZ for the treatment of Alzheimer's disease.
The announcement of positive preclinical results for HT-ALZ is a significant milestone for Hoth Therapeutics, as it may lead to further development and potential commercialization of the treatment. This news is likely to cause a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100